News

The Dutch National Growth Fund (NGF) has earmarked 20 billion euros for projects that impact structural and sustainable economic growth in the Netherlands. Are you planning to submit a proposal for round 3 in the Life Sciences & Health area?

Lygature’s Strategic Asset Sharing portfolio: an interview with Herman Verheij

The Innovative Health Initiative (IHI) builds on the results of the Innovative Medicines Initiative (IMI) with a broader scope and stakeholder base. IHI just launched its first two calls for proposals and in order to kick start new partnerships, they organized a broker event in Brussels recently.

During a symposium on 1 July on the concept of a self-learning healthcare system, the MLC Foundation announces its integration into Lygature.

The GNA NOW Consortium, which Lygature proudly coordinates, has reached an important milestone with the completion of the GLP toxicology studies for its NOSO-502 program. The results allow for the further development of the program to Phase 1.

The Pediatric Praziquantel Consortium, coordinated by Lygature, has been featured in the latest issue of the European & Developing Countries Clinical Trials Partnership (EDCTP) e-Magazine, with a focus on the work of the Consortium and interviews with two of its project members, Maurice Odiere (Kenya Medical Research Institute (KEMRI)) and Beatrice Greco (Merck).

The MLC Foundation aims to contribute to the conduct of responsible, high-quality medical research and health care. It does this through research, advice, drawing up relevant documents (regulations / agreements) and maintaining bonds with relevant external parties. The MLC Foundation is looking for a senior lawyer data protection law.

The combined Dutch Medicine Days and EUFEPS Annual Meeting 2022 (June 1-3, in Leiden) is an important and interesting meeting that brings together all stakeholders in medicine research. We’d like to invite our network to register as soon as possible!

The Dutch government invests €651 million in the life sciences & health-sector in the second round of the National Growth Fund.[1] The National Growth Fund was launched in 2020 to strengthen the earning power of the Netherlands. The Fund invests together with initiators in projects that generate sustainable economic growth on the long term.

Lygature is an essential partner in European public-private partnerships that bring together the expertise and capability to solve complex health challenges.

Today, the 1000th board meeting of the Medicines Evaluation Board (College ter Beoordeling van Geneesmiddelen) will take place. Lygature congratulates the MEB with this special occasion.

At the end of 2021, the Lygature Scientific Advisory Board convened for the fifth time. The meeting included two main topics: an update on the highlights and progress since the last meeting, and an outside-in discussion on scientific and societal trends.

Each year on 24 March, World Tuberculosis (TB) Day is commemorated to raise awareness of this devastating and deadly disease.

Administration of antithrombotic drugs during catheter treatment of stroke patients leads to an increased risk of intracerebral hemorrhage, with no beneficial effect on recovery. The researchers, led by Erasmus MC, expect their results to change worldwide guidelines for administration of antithrombotic drugs during catheter treatment of stroke.

The European Lead Factory (ELF), a pan-European drug discovery project which Lygature proudly coordinates, has helped identify two drug candidates for cancer treatment that have now progressed to phase 1 clinical trial testing.